| Identification | Back Directory | [Name]
Gadoteric acid | [CAS]
72573-82-1 | [Synonyms]
Gd-DOTA
Gadoteric
Gadotericaci
Gadoteric acid
Gadolinium 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetic acid
2,2',2''-(10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetate Gd3+
2-[4,7-bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
Gadolinate(1-),[1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7,kO10]-, hydrogen (1:1) | [EINECS(EC#)]
1533716-785-6 | [Molecular Formula]
C16H25GdN4O8 | [MDL Number]
MFCD00867227 | [MOL File]
72573-82-1.mol | [Molecular Weight]
558.65 |
| Hazard Information | Back Directory | [Uses]
Gadoteric Acid is used for magnetic resonance imaging. | [Definition]
ChEBI: A gadolinium coordination entity consisting of DOTA in which the four amino groups are bound to a central gadolinium atom. It is used (as its meglumine salt) in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patie
ts ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system. | [storage]
Store at -20°C |
|
|